Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

GoodRx Holdings, Inc. - Class A Common Stock (NQ:GDRX)

2.675 +0.025 (+0.94%)
Streaming Delayed Price Updated: 2:42 PM EDT, Jun 8, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about GoodRx Holdings, Inc. - Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
News headline image
GoodRx Launches GoodRx Companion, a New Subscription Designed to Lower Everyday Healthcare Costs
From GoodRx
Via Business Wire
News headline image
GoodRx Reports First Quarter 2026 Results
From GoodRx Holdings, Inc.
Via Business Wire
News headline image
GoodRx Expands Offerings to Now Include Ozempic® Pill for Type 2 Diabetes Patients
From GoodRx
Via Business Wire
News headline image
GoodRx Announces Date for First Quarter 2026 Earnings Release and Conference Call
From GoodRx Holdings, Inc.
Via Business Wire
News headline image
GoodRx Now Offers Access to Wegovy® HD at $399 Per Month Self-Pay Price
From GoodRx
Via Business Wire
News headline image
GoodRx Expands Access to Eli Lilly and Company’s New Oral GLP-1, Foundayo™, and Zepbound® KwikPen® with Self-Pay Pricing at More Than 70,000 Pharmacies Nationwide
From GoodRx
Via Business Wire
News headline image
GoodRx Partners with Viatris to Offer Up to 85% Savings on Established Brand Medications
From GoodRx
Via Business Wire
News headline image
GoodRx to Expand Employer-Sponsored Access to Zepbound® KwikPen®
From GoodRx
Via Business Wire
News headline image
GoodRx Reports Fourth Quarter and Full Year 2025 Results
From GoodRx Holdings, Inc.
Via Business Wire
News headline image
GoodRx Expands Into Employer Market With Launch of “GoodRx Employer Direct”
From GoodRx
Via Business Wire
News headline image
GoodRx Powers Pricing for Leading Brand Medications on TrumpRx
From GoodRx
Via Business Wire
News headline image
GoodRx Earns HITRUST i1 Certification for the Second Consecutive Year, Reinforcing Its Commitment to Protecting Healthcare Data at Scale
From GoodRx
Via Business Wire
News headline image
GoodRx Announces Date for Fourth Quarter and Full Year 2025 Earnings Release and Conference Call
From GoodRx Holdings, Inc.
Via Business Wire
News headline image
Surescripts and GoodRx Partner to Advance Patient Price Transparency
From Surescripts
Via Business Wire
News headline image
GoodRx Launches RxSmartSaver at Giant Eagle Pharmacies
From GoodRx
Via Business Wire
News headline image
GoodRx Now Offers Novo Nordisk’s Cash Price for the Launch of the Wegovy® Pill
From GoodRx
Via Business Wire
News headline image
GoodRx to Participate in the 44th Annual J.P. Morgan Healthcare Conference
From GoodRx Holdings, Inc.
Via Business Wire
News headline image
GoodRx Launches New $39 Per Month Weight Loss Telemedicine Subscription, Unveils Industry-Leading Introductory Cash Price of $199 Per Month for Ozempic® and Wegovy®
From GoodRx
Via Business Wire
News headline image
GoodRx Reports Third Quarter 2025 Results
From GoodRx Holdings, Inc.
Via Business Wire
News headline image
GoodRx Launches New Hair Loss Subscription for Men to Simplify Access to Affordable Treatment
From GoodRx
Via Business Wire
News headline image
GoodRx Announces Date for Third Quarter 2025 Earnings Release and Conference Call
From GoodRx Holdings, Inc.
Via Business Wire
News headline image
GoodRx Expands Affordable Access to Repatha® with Nearly 60% Savings
From GoodRx
Via Business Wire
News headline image
GoodRx Launches Brand Medication Savings Program at National Retail Pharmacy
From GoodRx
Via Business Wire
News headline image
GoodRx Saddles Up With “The Savings Wrangler,” a Bold New Brand Campaign to Tame the Wild West of Prescription Pricing
From GoodRx
Via Business Wire
News headline image
GoodRx Announces Collaboration with Novo Nordisk to Expand Access to Ozempic® and Wegovy® for $499-Per-Month
From GoodRx
Via Business Wire
News headline image
GoodRx Reports Second Quarter 2025 Results
From GoodRx Holdings, Inc.
Via Business Wire
News headline image
GoodRx Appoints Amazon Pharmacy Veteran Laura Jensen as President of Pharma Solutions
From GoodRx
Via Business Wire
News headline image
GOODRX INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of GoodRx Holdings, Inc. - GDRX
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
GoodRx Announces Date for Second Quarter 2025 Earnings Release and Conference Call
From GoodRx Holdings, Inc.
Via Business Wire
News headline image
GoodRx Launches New Erectile Dysfunction Subscription Service to Simplify Access and Eliminate Treatment Barriers
From GoodRx
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.